Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 1998; Volume 53,Issue 1

Accelerated Communication

  • You have access
    Nefiracetam Modulates Acetylcholine Receptor Currents via Two Different Signal Transduction Pathways
    Tomoyuki Nishizaki, Toshiyuki Matsuoka, Tamotsu Nomura, Katumi Sumikawa, Tadashi Shiotani, Shigeo Watabe and Mitsunobu Yoshii
    Molecular Pharmacology January 1998, 53 (1) 1-5; DOI: https://doi.org/10.1124/mol.53.1.1

Articles

  • You have access
    Up-Regulation of Neuropeptide Y-Y2 Receptors in an Animal Model of Temporal Lobe Epilepsy
    Christoph Schwarzer, Nikolaus Kofler and Günther Sperk
    Molecular Pharmacology January 1998, 53 (1) 6-13; DOI: https://doi.org/10.1124/mol.53.1.6
  • You have access
    Peroxisome Proliferator Activated Receptor-α Expression in Human Liver
    Colin N. A. Palmer, Mei-H. Hsu, Keith J. Griffin, Judy L. Raucy and Eric F. Johnson
    Molecular Pharmacology January 1998, 53 (1) 14-22; DOI: https://doi.org/10.1124/mol.53.1.14
  • You have access
    Characterization of the Rolipram-Sensitive, Cyclic AMP-Specific Phosphodiesterases: Identification and Differential Expression of Immunologically Distinct Forms in the Rat Brain
    Saveria Iona, Margherita Cuomo, Tamara Bushnik, Fabio Naro, Claudio Sette, Martin Hess, Earl R. Shelton and Marco Conti
    Molecular Pharmacology January 1998, 53 (1) 23-32; DOI: https://doi.org/10.1124/mol.53.1.23
  • You have access
    Nuclear Factor-κB Contributes to Excitotoxin-Induced Apoptosis in Rat Striatum
    Zheng-Hong Qin, Yumei Wang, Masami Nakai and Thomas N. Chase
    Molecular Pharmacology January 1998, 53 (1) 33-42; DOI: https://doi.org/10.1124/mol.53.1.33
  • You have access
    A Single-Stranded DNA Binding Site in the Human A1 Adenosine Receptor Gene Promoter
    Hongzu Ren and Gary L. Stiles
    Molecular Pharmacology January 1998, 53 (1) 43-51; DOI: https://doi.org/10.1124/mol.53.1.43
  • You have access
    Interaction between Iron Metabolism and 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Mice with Variants of the Ahr Gene: A Hepatic Oxidative Mechanism
    Andrew G. Smith, Bruce Clothier, Susan Robinson, Matthew J. Scullion, Philip Carthew, Richard Edwards, Jinli Luo, Chang Kee Lim and Michel Toledano
    Molecular Pharmacology January 1998, 53 (1) 52-61; DOI: https://doi.org/10.1124/mol.53.1.52
  • You have access
    Structure-Activity Analysis of the Interaction of Curacin A, the Potent Colchicine Site Antimitotic Agent, with Tubulin and Effects of Analogs on the Growth of MCF-7 Breast Cancer Cells
    Pascal Verdier-Pinard, Jing-Yu Lai, Hae-Dong Yoo, Jurong Yu, Brian Marquez, Dale G. Nagle, Mitch Nambu, James D. White, J. R. Falck, William H. Gerwick, Billy W. Day and Ernest Hamel
    Molecular Pharmacology January 1998, 53 (1) 62-76; DOI: https://doi.org/10.1124/mol.53.1.62
  • You have access
    Recognition of Specific Sequences in DNA by a Topoisomerase I Inhibitor Derived from the Antitumor Drug Rebeccamycin
    Christian Bailly, Pierre Colson, Claude Houssier, Elisabete Rodrigues-Pereira, Michelle Prudhomme and Michael J. Waring
    Molecular Pharmacology January 1998, 53 (1) 77-87; DOI: https://doi.org/10.1124/mol.53.1.77
  • You have access
    High Affinity Glutamate Transport in Rat Cortical Neurons in Culture
    Guang Jian Wang, Hye Joo Chung, Jamie Schnuer, Kara Pratt, Anthony C. Zable, Michael P. Kavanaugh and Paul A. Rosenberg
    Molecular Pharmacology January 1998, 53 (1) 88-96; DOI: https://doi.org/10.1124/mol.53.1.88
  • You have access
    Exposure of Human Vascular Smooth Muscle Cells to Raf-1 Antisense Oligodeoxynucleotides: Cellular Responses and Pharmacodynamic Implications
    Christoph Schumacher, Catherine L. Cioffi, Haamid Sharif, William Haston, Brett P. Monia and Lawrence Wennogle
    Molecular Pharmacology January 1998, 53 (1) 97-104; DOI: https://doi.org/10.1124/mol.53.1.97
  • You have access
    The Involvement of Novel Protein Kinase C Isozymes in Influencing Sensitivity of Breast Cancer MCF-7 Cells to Tumor Necrosis Factor-α
    Alakananda Basu
    Molecular Pharmacology January 1998, 53 (1) 105-111; DOI: https://doi.org/10.1124/mol.53.1.105
  • You have access
    Role of Oligosaccharides in the Pharmacokinetics of Tissue-Derived and Genetically Engineered Cholinesterases
    Ashima Saxena, Yacov Ashani, Lily Raveh, David Stevenson, Thakor Patel and B. P. Doctor
    Molecular Pharmacology January 1998, 53 (1) 112-122; DOI: https://doi.org/10.1124/mol.53.1.112
  • You have access
    Mechanism of YC-1-Induced Activation of Soluble Guanylyl Cyclase
    Andreas Friebe and Doris Koesling
    Molecular Pharmacology January 1998, 53 (1) 123-127; DOI: https://doi.org/10.1124/mol.53.1.123
  • You have access
    The Role of the Seventh Transmembrane Region in High Affinity Binding of a β2-Selective Agonist TA-2005
    Hideo Kikkawa, Masafumi Isogaya, Taku Nagao and Hitoshi Kurose
    Molecular Pharmacology January 1998, 53 (1) 128-134; DOI: https://doi.org/10.1124/mol.53.1.128
  • You have access
    Platelet-Activating Factor Induction of Activator Protein-1 Signaling in Bronchial Epithelial Cells
    Tricia D. Levan, John W. Bloom, Deanna G. Adams, Jennifer L. Hensel and Marilyn Halonen
    Molecular Pharmacology January 1998, 53 (1) 135-140; DOI: https://doi.org/10.1124/mol.53.1.135
  • You have access
    Kinetics of Anthracycline Efflux from Multidrug Resistance Protein-Expressing Cancer Cells Compared with P-Glycoprotein-Expressing Cancer Cells
    C. Marbeuf-Gueye, H. J. Broxterman, F. Dubru, W. Priebe and A. Garnier-Suillerot
    Molecular Pharmacology January 1998, 53 (1) 141-147; DOI: https://doi.org/10.1124/mol.53.1.141
  • You have access
    Effects of Ethanol and Anesthetics on Type 1 and 5 Metabotropic Glutamate Receptors Expressed in Xenopus laevis Oocytes
    Kouichiro Minami, Robert W. Gereau, Makiko Minami, Stephen F. Heinemann and R. Adron Harris
    Molecular Pharmacology January 1998, 53 (1) 148-156; DOI: https://doi.org/10.1124/mol.53.1.148
  • You have access
    Intracellular Metabolism of the N7-Substituted Acyclic Nucleoside Analog 2-Amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, a Potent Inhibitor of Herpesvirus Replication
    Johan Neyts, Jan Balzarini, Graciela Andrei, Zhu Chaoyong, Robert Snoeck, Albert Zimmermann, Thomas Mertens, Anna Karlsson and Erik De Clercq
    Molecular Pharmacology January 1998, 53 (1) 157-165; DOI: https://doi.org/10.1124/mol.53.1.157
  • You have access
    Steric Hindrance Mutagenesis versus Alanine Scan in Mapping of Ligand Binding Sites in the Tachykinin NK1 Receptor
    Birgitte Holst, Sannah Zoffmann, Christian E. Elling, Siv A. Hjorth and Thue W. Schwartz
    Molecular Pharmacology January 1998, 53 (1) 166-175; DOI: https://doi.org/10.1124/mol.53.1.166
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 53 (1)
Molecular Pharmacology
Vol. 53, Issue 1
1 Jan 1998
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Accelerated Communication
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics